Ensysce Biosciences (ENSC) Stock Receives $8 Price Target

By Amit Chowdhry ● Nov 22, 2022
  • The shares of Ensysce Biosciences (ENSC) recently received an $8 price target. These are the details.

The shares of Ensysce Biosciences (ENSC) recently received an $8 price target.

Price target: Reduced from split-adjusted $80 to $8

Rating: Buy

Analyst firm: Lake Street

Lake Street analysts adjusted the rating while noting that the target reflects the current market environment, multiple compression, and ongoing capital needs at current valuations. But they expect multiple value-driving data read-outs and clinical milestones over the next several quarters. And the analysts believe that the coming few quarters should be transformative for the company considering positive feedback from the FDA regarding a potential acute pain indication and data from the intranasal human abuse potential study.